| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY22 and earlierAlpha Plus |
|---|
| 92.24× | 92.24× | 137.22× | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.14× | 0.05× | 0.04× | — | ||
| 0.02× | 0.02× | 0.02× | 0.76× | ||
| 1.98× | 1.98× | 1.05× | — | ||
| 5.95× | 5.95× | −4.87× | −0.59× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | — | — | 137.22 | 92.24 | 92.24 | |
| Working Capital Turnover | — | — | 0.04 | 0.05 | 0.14 | |
| Asset Turnover | — | 0.76 | 0.02 | 0.02 | 0.02 | |
| Cash Conversion (CFO/Net Income) | — | — | 1.05 | 1.98 | 1.98 | |
| CFO/EBITDA | — | -0.59 | -4.87 | 5.95 | 5.95 |